FDA DEVICE FACTS
Ingenia 1.5T, Ingenia 1 5T S, Ingenia 1.5T CX, Ingenia 3.0T CX R5.4
Philips Medical Systems Nederland B.V.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
This system is a Magnetic Resonance Medical Electrical Systems indicated for use as a diagnostic device. The system can produce cross-sectional images, spectroscopic images and/or spectra in any orientation of the internal structure of the head, body or extremities.
Magnetic Resonance images represent the spatial distribution of protons or other nuclei with spin. Image appearance is determined by many different physical properties of the tissue and the anatomy, and the MR scan technique applied. The image acquisition process can be synchronized with the patient’s breathing or cardiac cycle. The systems can use combinations of images to produce physical parameters, and related derived images.
Images, spectra, and measurements of physical parameters, when interpreted by a trained physician, provide information that may assist the diagnosis and therapy planning. The accuracy of determined physical parameters depends on system and scan parameters, and must be controlled and validated by the clinical user. The use of contrast agents for diagnostic imaging applications should be performed consistent with the approved labeling for the contrast agent.
In addition the Philips MR systems provide imaging capabilities, such as MR fluoroscopy, to guide and evaluate interventional and minimally invasive procedures in the head, body and extremities.
MR Interventional procedures, performed inside or adjacent to the Philips MR system, must be performed with MR Conditional or MR Safe instrumentation as selected and evaluated by the clinical user for use with the specific MR system configuration in the hospital. The appropriateness and use of information from a Philips MR system for a specific interventional procedure and specific MR system configuration must be validated by the clinical user. Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging Bundled Abbreviated 510(k)
Premarket Notification [510(k)] Submission S5 Philips Medical Systems Nederland B.V. Ingenia 1.5T, Ingenia 1.5T S, Ingenia 1.5T CX, Ingenia 3.0T, and Ingenia 3.0T CX R5.4
Design Features/ Fundamental Scientific Technology: The proposed Ingenia 1.5T, Ingenia 1.5T S, Ingenia 1.5T CX, Ingenia 3.0T, and Ingenia 3.0T CX R5.4 with the Compressed SENSE feature are based on the principle that certain atomic nuclei present in the human body will emit a weak relaxation signal when placed in a strong magnetic field and excited by a radio signal at the precession frequency. The emitted relaxation signals are analyzed by the system and a computed image reconstruction is displayed on a video screen.
The principal technological components (magnet, transmit body coil, gradient coil, receive coils and patient support) of the proposed Ingenia 1.5T, Ingenia 1.5T S, Ingenia 1.5T CX, Ingenia 3.0T, and Ingenia 3.0T CX R5.4 with the Compressed SENSE feature are identical to those used in the legally marketed primary predicate device Ingenia 1.5T, Ingenia 1.5T S and Ingenia 3T R5.3 (K163116, 01/06/2017).
Compressed SENSE enables scan time reduction or improved spatial resolution through non-equidistant k-space sampling and regularized reconstruction methods with automatic parameter tuning. The Compressed SENSE feature allows ultra-high acceleration factors for shorter scan times and higher resolution in 2D and 3D imaging based on the principle of Compressed sensing in combination with SENSE. The use of Compressed SENSE is limited to non-contrast enhanced exams.
Based on the information provided above, the proposed Ingenia 1.5T, Ingenia 1.5T S, Ingenia 1.5T CX, Ingenia 3.0T, and Ingenia 3.0T CX R5.4 with the Compressed SENSE feature does not raise different questions of safety and effectiveness compare to the legally marketed primary predicate device Ingenia 1.5T, Ingenia 1.5T S and Ingenia 3T R5.3 (K163116, 01/06/2017). Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging Bundled Abbreviated 510(k)
Premarket Notification [510(k)] Submission S5 Philips Medical Systems Nederland B.V. Ingenia 1.5T, Ingenia 1.5T S, Ingenia 1.5T CX, Ingenia 3.0T, and Ingenia 3.0T CX R5.4
Summary of Non-Clinical
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。